Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.14 USD | -4.66% | +4.92% | +22.57% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.57% | 789M | |
+10.56% | 115B | |
+12.19% | 106B | |
-4.62% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.53% | 17.56B | |
-40.50% | 17.32B | |
+6.02% | 14.03B | |
+30.35% | 12.13B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Wave Life Sciences : Truist Adjusts Price Target on WAVE Life Sciences to $17 From $27, Maintains Buy Rating